Attached files

file filename
10-K - 10-K - Seagen Inc.a10k2019.htm
EX-32.2 - EXHIBIT 32.2 - Seagen Inc.ex-322201910k.htm
EX-32.1 - EXHIBIT 32.1 - Seagen Inc.ex-321201910k.htm
EX-31.2 - EXHIBIT 31.2 - Seagen Inc.ex-312201910k.htm
EX-31.1 - EXHIBIT 31.1 - Seagen Inc.ex-311201910k.htm
EX-21.1 - EXHIBIT 21.1 - Seagen Inc.ex-211201910k.htm
EX-10.88 - EXHIBIT 10.88 - Seagen Inc.ex-1088201910k.htm
EX-10.87 - EXHIBIT 10.87 - Seagen Inc.ex-1087201910k.htm
EX-10.86 - EXHIBIT 10.86 - Seagen Inc.ex-1086201910k.htm
EX-10.85 - EXHIBIT 10.85 - Seagen Inc.ex-1085201910k.htm
EX-10.84 - EXHIBIT 10.84 - Seagen Inc.ex-1084201910k.htm
EX-10.83 - EXHIBIT 10.83 - Seagen Inc.ex-1083201910k.htm
EX-10.82 - EXHIBIT 10.82 - Seagen Inc.ex-1082201910k.htm
EX-10.81 - EXHIBIT 10.81 - Seagen Inc.ex-1081201910k.htm
EX-10.80 - EXHIBIT 10.80 - Seagen Inc.ex-1080201910k.htm
EX-10.29 - EXHIBIT 10.29 - Seagen Inc.ex-1029201910k.htm
EX-10.1 - EXHIBIT 10.1 - Seagen Inc.ex-101201910k.htm
EX-4.1 - EXHIBIT 4.1 - Seagen Inc.ex-41201910k.htm

Exhibit 23.1


CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-232397, 333-226370, 333-212688, 333-204331, 333-197992, 333-188446, 333-176144, 333-168672, 333-148188, 333-56670) and Form S-3 (No. 333-222793) of Seattle Genetics, Inc. of our report dated February 6, 2020 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.

/s/ PricewaterhouseCoopers LLP
Seattle, Washington
February 6, 2020



1